| Translated title of the contribution | Cost-effectiveness analysis of lisocabtagene maraleucel for patients with relapsed or refractory diffuse large B-cell lymphoma after first-line chemoimmunotherapy in Taiwan |
|---|---|
| Original language | Chinese (Traditional) |
| Supervisors/Advisors |
|
| State | Published - 2024 |
| Externally published | Yes |
嵌合抗原受體T細胞療法用於經一線化學免疫療法後復發或難治性瀰漫性大B細胞淋巴瘤之成本效益分析:以lisocabtagene maraleucel為例
張詠欣
Research output: Types of Thesis › Master's thesis